特集 : 国別レポートが13,000件から検索可能になりました!

特集 : 海外市場の委託調査がセミカスタムベースでお手軽にできます

株式会社グローバルインフォメーション
市場調査レポート
商品コード
953527

ワクチン管理デバイスの世界市場:業界の動向と2027年までの予測

Global Vaccine Administration Devices Market - Industry Trends and Forecast to 2027

出版日: | 発行: Data Bridge Market Research Private Limited | ページ情報: 英文 510 Pages | 納期: 即日から翌営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=105.45円
ワクチン管理デバイスの世界市場:業界の動向と2027年までの予測
出版日: 2020年07月01日
発行: Data Bridge Market Research Private Limited
ページ情報: 英文 510 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界のワクチン管理デバイス市場は、2020年から2027年の予測期間中に7.4%のCAGRで大幅に成長すると予測されています。同市場の主な成長要因には、ワクチン分野の研究の成長や、政府の支援と投資の増加などが挙げられます。

当レポートは、世界のワクチン管理デバイス市場について調査しており、市場の成長および抑制要因、課題や機会、製品・投与経路・タイプ・ブランド・投与量・ワクチンタイプ・モダリティ・ユーザビリティ・エンドユーザー・流通チャネル・地域別の市場分析、競合情勢、主要企業のプロファイル等の情報を提供しています。

目次

第1章 イントロダクション

第2章 市場細分化

第3章 エグゼクティブサマリー

第4章 市場概要

  • 促進要因
    • 増大する予防接種率
    • 予防接種プログラムとキャンペーンの拡大
    • 予防接種分野の研究の成長
    • 政府のサポートと投資の増加
    • 新規ワクチンの開発
  • 抑制要因
    • ワクチンの保管
    • ワクチンの粘膜送達に関する課題
    • 注射と針刺しに関連する患者の恐怖
  • 市場機会
    • 技術の進歩
    • 市場参入企業による戦略的イニシアチブ
    • ニードルフリーデバイスの優先度の向上
    • 新しい技術への投資の増加
  • 課題
    • 対象となるワクチンの存在
    • ワクチンの副作用
    • ワクチン投与のための熟練した人材の欠如

第5章 世界市場:規制

第6章 COVID-19パンデミックの影響

  • 価格への影響
  • サプライチェーンへの影響
  • 需要への影響
  • 製造業者のための戦略的決定
  • 結論

第7章 市場分析:製品別

  • 概要
  • シリンジ
  • オートインジェクター
  • ジェットインジェクター
  • マイクロニードル
  • 吸入/肺送達
  • マイクロインジェクションシステム
  • ペン型インジェクターデバイス
  • 生分解性インプラント
  • エレクトロポレーションベースの無針注射システム
  • BUCCAL / SUBLINGUALワクチン接種システム
  • 自動インジェクタートレーナーデバイス
  • その他

第8章 市場分析:投与経路別

  • 概要
  • 筋肉内ワクチン接種
  • 皮下ワクチン接種
  • 皮内ワクチン接種

第9章 市場分析:タイプ別

  • 概要
  • 市販のワクチン
  • 臨床段階のワクチン

第10章 市場分析:ブランド別

  • 概要
  • BD ACCUSPRAY NASAL SPRAY SYSTEM
  • BD HYPAK FOR VACCINES GLASS PRE-FILLABLE SYRINGE SYSTEM
  • BD UNIJECT AUTO-DISABLE PRE-FILLABLE INJECTION SYSTEM
  • PLAJEX
  • GX RTF CLEARJECT
  • GX INNOSAFE
  • その他

第11章 市場分析:投与量別

  • 概要
  • 固定
  • 変動

第12章 市場分析:ワクチンタイプ別

  • 概要
  • 二価経口ポリオワクチン
  • BCGワクチン
  • 破傷風ジフテリアワクチン
  • DTP-HEPB-HIBワクチン
  • インフルエンザワクチン
  • 肺炎球菌ワクチン
  • 麻疹ワクチン
  • その他

第13章 市場分析:モダリティ別

  • 概要
  • 自動ワクチン投与装置
  • 手動ワクチン投与装置

第14章 市場分析:ユーザビリティ別

  • 概要
  • 使い捨て
  • 再利用可能

第15章 市場分析:エンドユーザー別

  • 概要
  • 病院
  • コミュニティセンター
  • ホームケア
  • 研究・学術機関
  • 外来手術センター
  • その他

第16章 市場分析:流通チャネル別

  • 概要
  • 直接入札
  • 小売売上高
    • 病院薬局
    • 薬局
    • オンライン薬局
  • その他

第17章 市場分析:地域別

  • 概要
  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • オランダ
    • スペイン
    • ロシア
    • スイス
    • トルコ
    • ベルギー
    • その他
  • アジア太平洋地域
    • 日本
    • 中国
    • オーストラリア
    • 韓国
    • インド
    • シンガポール
    • マレーシア
    • タイ
    • インドネシア
    • フィリピン
    • その他
  • 南米
    • ブラジル
    • アルゼンチン
    • 南米
  • 中東・アフリカ
    • サウジアラビア
    • 南アフリカ
    • アラブ首長国連邦
    • イスラエル
    • エジプト
    • その他

第18章 世界市場・企業情勢

  • 企業シェア分析:世界
  • 企業シェア分析:北米
  • 企業シェア分析:欧州
  • 企業シェア分析:アジア太平洋地域

第19章 SWOT

第20章 企業プロファイル

  • BD
  • TERUMO EUROPE NV (テルモ株式会社)
  • WEST PHARMACEUTICAL SERVICES, INC.
  • SCHOTT AG (A SUBSIDIARY OF CARL-ZEISS-STIFTUNG)
  • 3M
  • ANTARES PHARMA
  • BESPAK EUROPE LTD.
  • CORIUM INC.
  • D'ANTONIO CONSULTANTS INTERNATIONAL, INC.
  • ENESI
  • IHEALTHNET LLC
  • INJEX UK
  • INOVIO PHARMACEUTICALS
  • MEDICAL INTERNATIONAL TECHNOLOGIES (MIT CANADA) INC.
  • MICROPOINT TECHNOLGIES
  • MYLAN PHARMACEUTICALS INC. (A SUBSIDIARY OF MYLAN N.V.)
  • MYSTIC PHARMACEUTICALS
  • NANOPASS
  • PHARMAJET
  • STAR SYRINGE LIMITED
  • VAXXAS PTY LTD

第21章 アンケート

第22章 関連レポート

図表

LIST OF FIGURES

  • FIGURE 1 GLOBAL VACCINE ADMINISTRATION DEVICES MARKET: SEGMENTATION 64
  • FIGURE 2 GLOBAL VACCINE ADMINISTRATION DEVICES MARKET : DATA TRIANGULATION 67
  • FIGURE 3 GLOBAL VACCINE ADMINISTRATION DEVICES MARKET: DROC ANALYSIS 68
  • FIGURE 4 GLOBAL VACCINE ADMINISTRATION DEVICES MARKET: GLOBAL VS REGIONAL MARKET ANALYSIS 69
  • FIGURE 5 GLOBAL VACCINE ADMINISTRATION DEVICES MARKET: COMPANY RESEARCH ANALYSIS 69
  • FIGURE 6 GLOBAL VACCINE ADMINISTRATION DEVICES MARKET: MULTIVARIATE MODELLING 70
  • FIGURE 7 GLOBAL VACCINE ADMINISTRATION DEVICES MARKET: INTERVIEW DEMOGRAPHICS 71
  • FIGURE 8 GLOBAL VACCINE ADMINISTRATION DEVICES MARKET: DBMR MARKET POSITION GRID 72
  • FIGURE 9 GLOBAL VACCINE ADMINISTRATION DEVICES MARKET: VENDOR SHARE ANALYSIS 73
  • FIGURE 10 GLOBAL VACCINE ADMINISTRATION DEVICES MARKET: MARKET APPLICATION COVERAGE GRID 74
  • FIGURE 11 GLOBAL VACCINE ADMINISTRATION DEVICES MARKET: SEGMENTATION 79
  • FIGURE 12 NORTH AMERICA IS EXPECTED TO DOMINATE AS WELL AS GROW IN THE GLOBAL VACCINE ADMINISTRATION DEVICES MARKET IN THE FORECAST PERIOD OF 2020 TO 2027 80
  • FIGURE 13 GROWING RESEARCH IN THE FIELD OF VACCINATION AND GROWING IMMUNIZATION COVERAGE ARE EXPECTED TO DRIVE THE GLOBAL VACCINE ADMINISTRATION DEVICES MARKET IN THE FORECAST PERIOD OF 2020 TO 2027 81
  • FIGURE 14 SYRINGES SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE GLOBAL VACCINE ADMINISTRATION DEVICES MARKET IN 2020 & 2027 81
  • FIGURE 15 NORTH AMERICA IS THE FASTEST GROWING MARKET FOR VACCINE ADMINISTRATION DEVICES MANUFACTURERS IN THE FORECAST PERIOD OF 2020 TO 2027 82
  • FIGURE 16 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES OF GLOBAL VACCINE ADMINISTRATION DEVICES MARKET 84
  • FIGURE 17 GLOBAL VACCINE ADMINISTRATION DEVICES MARKET: BY PRODUCT, 2019 98
  • FIGURE 18 GLOBAL VACCINE ADMINISTRATION DEVICES MARKET: BY PRODUCT, 2019-2027 (USD MILLION) 99
  • FIGURE 19 GLOBAL VACCINE ADMINISTRATION DEVICES MARKET: BY PRODUCT, CAGR (2020-2027) 99
  • FIGURE 20 GLOBAL VACCINE ADMINISTRATION DEVICES MARKET: BY PRODUCT, LIFELINE CURVE 100
  • FIGURE 21 GLOBAL VACCINE ADMINISTRATION DEVICES MARKET: BY ROUTE OF ADMINISTRATION, 2019 113
  • FIGURE 22 GLOBAL VACCINE ADMINISTRATION DEVICES MARKET: BY ROUTE OF ADMINISTRATION, 2019-2027 (USD MILLION) 114
  • FIGURE 23 GLOBAL VACCINE ADMINISTRATION DEVICES MARKET: BY ROUTE OF ADMINISTRATION, CAGR (2020-2027) 114
  • FIGURE 24 GLOBAL VACCINE ADMINISTRATION DEVICES MARKET: BY ROUTE OF ADMINISTRATION, LIFELINE CURVE 115
  • FIGURE 25 GLOBAL VACCINE ADMINISTRATION DEVICES MARKET: BY TYPE, 2019 122
  • FIGURE 26 GLOBAL VACCINE ADMINISTRATION DEVICES MARKET: BY TYPE, 2019-2027 (USD MILLION) 123
  • FIGURE 27 GLOBAL VACCINE ADMINISTRATION DEVICES MARKET: BY TYPE, CAGR (2020-2027) 123
  • FIGURE 28 GLOBAL VACCINE ADMINISTRATION DEVICES MARKET: BY TYPE, LIFELINE CURVE 124
  • FIGURE 29 GLOBAL VACCINE ADMINISTRATION DEVICES MARKET: BY BRAND , 2019 130
  • FIGURE 30 GLOBAL VACCINE ADMINISTRATION DEVICES MARKET: BY BRAND, 2019-2027 (USD MILLION) 131
  • FIGURE 31 GLOBAL VACCINE ADMINISTRATION DEVICES MARKET: BY BRAND, CAGR (2020-2027) 131
  • FIGURE 32 GLOBAL VACCINE ADMINISTRATION DEVICES MARKET: BY BRAND, LIFELINE CURVE 132
  • FIGURE 33 GLOBAL VACCINE ADMINISTRATION DEVICES MARKET: BY DOSAGE, 2019 139
  • FIGURE 34 GLOBAL VACCINE ADMINISTRATION DEVICES MARKET: BY DOSAGE, 2019-2027 (USD MILLION) 140
  • FIGURE 35 GLOBAL VACCINE ADMINISTRATION DEVICES MARKET: BY DOSAGE, CAGR (2020-2027) 140
  • FIGURE 36 GLOBAL VACCINE ADMINISTRATION DEVICES MARKET: BY DOSAGE, LIFELINE CURVE 141
  • FIGURE 37 GLOBAL VACCINE ADMINISTRATION DEVICES MARKET: BY VACCINE TYPE, 2019 145
  • FIGURE 38 GLOBAL VACCINE ADMINISTRATION DEVICES MARKET: BY VACCINE TYPE, 2019-2027 (USD MILLION) 146
  • FIGURE 39 GLOBAL VACCINE ADMINISTRATION DEVICES MARKET: BY VACCINE TYPE, CAGR (2020-2027) 146
  • FIGURE 40 GLOBAL VACCINE ADMINISTRATION DEVICES MARKET: BY VACCINE TYPE, LIFELINE CURVE 147
  • FIGURE 41 GLOBAL VACCINE ADMINISTRATION DEVICES MARKET: BY MODALITY, 2019 155
  • FIGURE 42 GLOBAL VACCINE ADMINISTRATION DEVICES MARKET: BY MODALITY, 2019-2027 (USD MILLION) 156
  • FIGURE 43 GLOBAL VACCINE ADMINISTRATION DEVICES MARKET: BY MODALITY, CAGR (2020-2027) 156
  • FIGURE 44 GLOBAL VACCINE ADMINISTRATION DEVICES MARKET: BY MODALITY, LIFELINE CURVE 157
  • FIGURE 45 GLOBAL VACCINE ADMINISTRATION DEVICES MARKET: BY USABILITY, 2019 161
  • FIGURE 46 GLOBAL VACCINE ADMINISTRATION DEVICES MARKET: BY USABILITY, 2019-2027 (USD MILLION) 162
  • FIGURE 47 GLOBAL VACCINE ADMINISTRATION DEVICES MARKET: BY USABILITY, CAGR (2020-2027) 162
  • FIGURE 48 GLOBAL VACCINE ADMINISTRATION DEVICES MARKET: BY USABILITY, LIFELINE CURVE 163
  • FIGURE 49 GLOBAL VACCINE ADMINISTRATION DEVICES MARKET: BY END USER, 2019 167
  • FIGURE 50 GLOBAL VACCINE ADMINISTRATION DEVICES MARKET: BY END USER, 2019-2027 (USD MILLION) 168
  • FIGURE 51 GLOBAL VACCINE ADMINISTRATION DEVICES MARKET: BY END USER, CAGR (2020-2027) 168
  • FIGURE 52 GLOBAL VACCINE ADMINISTRATION DEVICES MARKET: BY END USER, LIFELINE CURVE 169
  • FIGURE 53 GLOBAL VACCINE ADMINISTRATION DEVICES MARKET: BY DISTRIBUTION CHANNEL, 2019 175
  • FIGURE 54 GLOBAL VACCINE ADMINISTRATION DEVICES MARKET: BY DISTRIBUTION CHANNEL, 2019-2027 (USD MILLION) 176
  • FIGURE 55 GLOBAL VACCINE ADMINISTRATION DEVICES MARKET: BY DISTRIBUTION CHANNEL, CAGR (2020-2027) 176
  • FIGURE 56 GLOBAL VACCINE ADMINISTRATION DEVICES MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE 177
  • FIGURE 57 GLOBAL VACCINE ADMINISTRATION DEVICES MARKET: SNAPSHOT (2019) 183
  • FIGURE 58 GLOBAL VACCINE ADMINISTRATION DEVICES MARKET: BY REGION (2019) 185
  • FIGURE 59 GLOBAL VACCINE ADMINISTRATION DEVICES MARKET: BY REGION (2020 & 2027) 185
  • FIGURE 60 GLOBAL VACCINE ADMINISTRATION DEVICES MARKET: BY REGION (2019 & 2027) 186
  • FIGURE 61 GLOBAL VACCINE ADMINISTRATION DEVICES MARKET: BY PRODUCT (2020-2027) 186
  • FIGURE 62 NORTH AMERICA VACCINE ADMINISTRATION DEVICES MARKET: SNAPSHOT (2019) 188
  • FIGURE 63 NORTH AMERICA VACCINE ADMINISTRATION DEVICES MARKET: BY COUNTRY (2019) 190
  • FIGURE 64 NORTH AMERICA VACCINE ADMINISTRATION DEVICES MARKET: BY COUNTRY (2020 & 2027) 190
  • FIGURE 65 NORTH AMERICA VACCINE ADMINISTRATION DEVICES MARKET: BY COUNTRY (2019 & 2027) 191
  • FIGURE 66 NORTH AMERICA VACCINE ADMINISTRATION DEVICES MARKET: BY TYPE (2020-2027) 191
  • FIGURE 67 EUROPE VACCINE ADMINISTRATION DEVICES MARKET: SNAPSHOT (2019) 220
  • FIGURE 68 EUROPE VACCINE ADMINISTRATION DEVICES MARKET: BY COUNTRY (2019) 222
  • FIGURE 69 EUROPE VACCINE ADMINISTRATION DEVICES MARKET: BY COUNTRY (2020 & 2027) 222
  • FIGURE 70 EUROPE VACCINE ADMINISTRATION DEVICES MARKET: BY COUNTRY (2019 & 2027) 223
  • FIGURE 71 EUROPE VACCINE ADMINISTRATION DEVICES MARKET: BY PRODUCT (2020-2027) 223
  • FIGURE 72 ASIA PACIFIC VACCINE ADMINISTRATION DEVICES MARKET: SNAPSHOT (2019) 302
  • FIGURE 73 ASIA PACIFIC VACCINE ADMINISTRATION DEVICES MARKET: BY COUNTRY (2019) 304
  • FIGURE 74 ASIA PACIFIC VACCINE ADMINISTRATION DEVICES MARKET: BY COUNTRY (2020 & 2027) 304
  • FIGURE 75 ASIA PACIFIC VACCINE ADMINISTRATION DEVICES MARKET: BY COUNTRY (2019 & 2027) 305
  • FIGURE 76 ASIA PACIFIC VACCINE ADMINISTRATION DEVICES MARKET: BY PRODUCT (2020-2027) 305
  • FIGURE 77 SOUTH AMERICA VACCINE ADMINISTRATION DEVICES MARKET: SNAPSHOT (2019) 384
  • FIGURE 78 SOUTH AMERICA VACCINE ADMINISTRATION DEVICES MARKET: BY COUNTRY (2019) 386
  • FIGURE 79 SOUTH AMERICA VACCINE ADMINISTRATION DEVICES MARKET: BY COUNTRY (2020 & 2027) 386
  • FIGURE 80 SOUTH AMERICA VACCINE ADMINISTRATION DEVICES MARKET: BY COUNTRY (2019 & 2027) 387
  • FIGURE 81 SOUTH AMERICA VACCINE ADMINISTRATION DEVICES MARKET: BY TYPE (2020-2027) 387
  • FIGURE 82 MIDDLE EAST & AFRICA VACCINE ADMINISTRATION DEVICES MARKET: SNAPSHOT (2019) 416
  • FIGURE 83 MIDDLE EAST & AFRICA VACCINE ADMINISTRATION DEVICES MARKET: BY COUNTRY (2019) 418
  • FIGURE 84 MIDDLE EAST & AFRICA VACCINE ADMINISTRATION DEVICES MARKET: BY COUNTRY (2020 & 2027) 418
  • FIGURE 85 MIDDLE EAST & AFRICA VACCINE ADMINISTRATION DEVICES MARKET: BY COUNTRY (2019 & 2027) 419
  • FIGURE 86 MIDDLE EAST & AFRICA VACCINE ADMINISTRATION DEVICES MARKET: BY PRODUCT (2020-2027) 419
  • FIGURE 87 GLOBAL VACCINE ADMINISTRATION DEVICES MARKET: COMPANY SHARE 2019 (%) 463
  • FIGURE 88 NORTH AMERICA VACCINE ADMINISTRATION DEVICES MARKET: COMPANY SHARE 2019 (%) 464
  • FIGURE 89 EUROPE VACCINE ADMINISTRATION DEVICES MARKET: COMPANY SHARE 2019 (%) 465
  • FIGURE 90 FIGURE4 ASIA-PACIFIC VACCINE ADMINISTRATION DEVICES MARKET: COMPANY SHARE 2019 (%) 466
目次

Global vaccine administration devices market is projected to register a substantial CAGR of 7.4% in the forecast period of 2020 to 2027. The new market report contains data for the historic year 2018, the base year of calculation is 2019 and the forecast period is 2020 to 2027.

Market Segmentation:

Global Vaccine Administration Devices Market, By Product (Syringes, Auto Injectors, Jet Injectors, Micro Needles, Inhalation/Pulmonary Delivery, Microinjection System, Pen Injector Devices, Biodegradable Implants, Electroporation-Based Needle Free Injection Systems, Buccal /Sublingual Vaccine Delivery Systems, Auto-Injector Trainer Devices and Others Devices), Route of Administration (Intramuscular, Subcutaneous, Intradermal), Type (Marketed Vaccines and Clinical-Stage Vaccines (Electroporation)), Brand (BD Accuspray Nasal Spray System, BD Hypak for Vaccines Glass Pre-Fillable Syringe System, BD Uniject Auto-Disable Pre-Fillable Injection System, Gx InnoSafe, Gx RTF ClearJect, Plajex, Others), Dosage (Fixed and Variable), Vaccine Type (Bivalent Oral PolioVaccine, BCG Vaccine, Tetanus-Diphtheria Vaccine, DTP-HEPB-HIB Vaccine, Influenza Vaccine, Pneumococcal Conjugate Vaccine, Measles Vaccine, Others), Modality (Automatic Vaccine Administration Device and Manual Vaccine Administration Device), Usability (Disposable and Reusable), End User (Hospitals, Community Centers, Homecare Setting, Research and Academic Institutes, Ambulatory Surgical Center, Others), Distribution Channel (Direct Tenders, Retail Sales, Others), Country (U.S., Canada, Mexico, Germany, France, Italy, U.K., Spain, Netherlands, Russia, Switzerland, Belgium, Turkey, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, Saudi Arabia, South Africa, UAE, Israel, Egypt and Rest of Middle East and Africa) Industry Trends and Forecast to 2027

Some of the major factors contributing to the growth of global vaccine administration devices market are:

Growing research in the field of vaccination

Increasing government support and investment

Market Players:

The key market players for global vaccine administration devices market are listed below:

BD

INOVIO Pharmaceuticals

PharmaJet

Vaxxas Pty Ltd

Gerresheimer AG

Corium Inc.

iHealthNet LLC

Enesi

Micropoint Technolgies

SCHOTT AG (a subsidiary of Carl-Zeiss-Stiftung)

3M

Mystic Pharmaceuticals

Star Syringe Limited

NanoPass

Terumo Europe NV (a subsidiary of Terumo Corporation)

D'Antonio Consultants International, Inc.

West Pharmaceutical Services, Inc.

Bespak Europe Ltd.

Mylan Pharmaceuticals Inc. (a subsidiary of Mylan N.V.)

Medical International Technologies (MIT Canada) Inc.

Antares Pharma

InjexUK

TABLE OF CONTENTS

1 INTRODUCTION 55

  • 1.1 OBJECTIVES OF THE STUDY 55
  • 1.2 MARKET DEFINITION 55
  • 1.3 OVERVIEW OF GLOBAL VACCINE ADMINISTRATION DEVICES MARKET 55
  • 1.4 LIMITATIONS 57
  • 1.5 MARKETS COVERED 58

2 MARKET SEGMENTATION 64

  • 2.1 MARKETS COVERED 64
  • 2.2 GEOGRAPHICAL SCOPE 65
  • 2.3 YEARS CONSIDERED FOR THE STUDY 66
  • 2.4 CURRENCY AND PRICING 66
  • 2.5 DBMR TRIPOD DATA VALIDATION MODEL 67
  • 2.6 MULTIVARIATE MODELLING 70
  • 2.7 PRODUCT LIFELINE CURVE IN GLOBAL VACCINE ADMINISTRATION DEVICES MARKET 70
  • 2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 71
  • 2.9 DBMR MARKET POSITION GRID 72
  • 2.10 VENDOR SHARE ANALYSIS 73
  • 2.11 MARKET APPLICATION COVERAGE GRID 74
  • 2.12 SECONDARY SOURCES 75
  • 2.13 ASSUMPTIONS 75

3 EXECUTIVE SUMMARY 76

4 MARKET OVERVIEW 83

  • 4.1 DRIVERS 85
    • 4.1.1 GROWING IMMUNIZATION COVERAGE 85
    • 4.1.2 RISING IMMUNIZATION PROGRAMS AND CAMPAIGNS 85
    • 4.1.3 GROWING RESEARCH IN THE FIELD OF VACCINATION 86
    • 4.1.4 INCREASING GOVERNMENT SUPPORT AND INVESTMENT 87
    • 4.1.5 DEVELOPMENT OF NOVEL VACCINES 87
  • 4.2 RESTRAINTS 88
    • 4.2.1 VACCINE STORAGE 88
    • 4.2.2 CHALLENGE FOR MUCOSAL DELIVERY OF VACCINES 88
    • 4.2.3 FEAR AMONG PATIENTS RELATED TO INJECTIONS AND NEEDLE STICKS 89
  • 4.3 OPPORTUNITIES 90
    • 4.3.1 TECHNOLOGICAL ADVANCEMENT 90
    • 4.3.2 STRATEGIC INITIATIVES BY MARKET PLAYERS 90
    • 4.3.3 GROWING PREFERENCE FOR NEEDLE-FREE DEVICES 91
    • 4.3.4 INCREASING INVESTMENT IN NEW TECHNOLOGIES 91
  • 4.4 CHALLENGES 92
    • 4.4.1 EXISTENCE OF EDIBLE VACCINES 92
    • 4.4.2 SIDE EFFECTS CAUSED BY VACCINES 92
    • 4.4.3 LACK OF SKILLED RESOURCES FOR VACCINE ADMINISTRATION 93

5 GLOBAL VACCINE ADMINSTRATION DEVICES MARKET: REGULATIONS 94

6 IMPACT OF COVID-19 PANDEMIC ON THE VACCINE ADMINISTRATION DEVICES MARKET 95

  • 6.1 IMPACT ON PRICE 95
  • 6.2 IMPACT ON SUPPLY CHAIN 95
  • 6.3 IMPACT ON DEMAND 95
  • 6.4 STRATEGIC DECISIONS FOR MANUFACTURERS 96
  • 6.5 CONCLUSION 96

7 GLOBAL VACCINE ADMINISTRATION DEVICES MARKET, BY PRODUCT 97

  • 7.1 OVERVIEW 98
  • 7.2 SYRINGES 101
  • 7.3 AUTO INJECTOR 101
    • 7.3.1 INTRAMUSCULAR 102
    • 7.3.2 SUBCUTANEOUS 102
  • 7.4 JET INJECTORS 102
    • 7.4.1 DISPOSABLE CARTRIDGE JET INJECTOR (DCJI) WITH PREFILLED UNIT DOSE CARTRIDGES 103
    • 7.4.2 SINGLE-USE DISPOSABLE JET INJECTORS (SUDJI) 104
    • 7.4.3 DISPOSABLE CARTRIDGE JET INJECTORS (DCJI): END-USER FILLING. 104
    • 7.4.4 SOLID PARTICLE JET INJECTORS 104
  • 7.5 MICRO NEEDLES 104
    • 7.5.1 HOLLOW MICRONEEDLES 105
    • 7.5.2 VACCINE -COATED MICRONEEDLES 105
    • 7.5.3 DISSOLVABLE/BIODEGRADABLE MICRONEEDLES 105
    • 7.5.4 SOLID MICRONEEDLES 105
  • 7.6 INHALATION/PULMONARY DELIVERY 105
    • 7.6.1 POWDER INHALATION 106
    • 7.6.2 LIQUID INHALATION 106
  • 7.7 MICROINJECTION SYSTEMS 106
  • 7.8 PEN-INJECTOR DEVICES 107
  • 7.9 BIODEGRADABLE IMPLANTS 108
  • 7.10 ELECTROPORATION-BASED NEEDLE FREE INJECTION SYSTEMS 109
  • 7.11 BUCCAL / SUBLINGUAL VACCINE DELIVERY SYSTEMS 109
  • 7.12 AUTO-INJECTOR TRAINER DEVICES 110
  • 7.13 OTHER DEVICES 111

8 GLOBAL VACCINE ADMINISTRATION DEVICES MARKET, BY ROUTE OF ADMINSTRATION 112

  • 8.1 OVERVIEW 113
  • 8.2 INTRAMUSCULAR VACCINATION 116
    • 8.2.1 SYRINGES 117
    • 8.2.2 AUTO INJECTORS 117
    • 8.2.3 JET INJECTORS 117
    • 8.2.4 ELECTROPORATION- BASED NEEDLE FREE INJECTION SYSTEMS 117
    • 8.2.5 BIODEGRADABLE IMPLANTS 117
  • 8.3 SUBCUTANEOUS VACCINATION 117
    • 8.3.1 SYRINGES 118
    • 8.3.2 AUTO INJECTORS 118
    • 8.3.3 JET INJECTORS 118
    • 8.3.4 ELECTROPORATION- BASED NEEDLE FREE INJECTION SYSTEMS 118
    • 8.3.5 BIODEGRADABLE IMPLANTS 119
  • 8.4 INTRADERMAL VACCINATION 119
    • 8.4.1 SYRINGES 120
    • 8.4.2 AUTO INJECTORS 120
    • 8.4.3 JET INJECTORS 120
    • 8.4.4 ELECTROPORATION- BASED NEEDLE FREE INJECTION SYSTEMS 120
    • 8.4.5 BIODEGRADABLE IMPLANTS 120

9 GLOBAL VACCINE ADMINISTRATION DEVICES MARKET, BY TYPE 121

  • 9.1 OVERVIEW 122
  • 9.2 MARKETED- VACCINES 124
    • 9.2.1 SYRINGES 125
    • 9.2.2 AUTOINJECTORS 125
      • 9.2.2.1 INTRAMUSCULAR 126
      • 9.2.2.2 SUBCUTANEUOS 126
    • 9.2.3 JET INJECTORS 126
    • 9.2.4 MICRONEEDLES 126
    • 9.2.5 AEROSOL/DRY POWDER INHALATION 126
    • 9.2.6 MICROINJECTION SYSTEM 126
    • 9.2.7 BIODEGRADABLE IMPLANTS 126
    • 9.2.8 ELECTROPORATION- BASED NEEDLE FREE INJECTION SYSTEMS 127
    • 9.2.9 BUCCAL /SUBLINGUAL VACCINE DELIVERY SYSTEMS 127
    • 9.2.10 OTHERS DEVICES 127
  • 9.3 CLINICAL- STAGE VACCINES 127

10 GLOBAL VACCINE ADMINISTRATION DEVICES MARKET, BY BRAND 129

  • 10.1 OVERVIEW 130
  • 10.2 BD ACCUSPRAY NASAL SPRAY SYSTEM 133
  • 10.3 BD HYPAK FOR VACCINES GLASS PRE-FILLABLE SYRINGE SYSTEM 133
  • 10.4 BD UNIJECT AUTO-DISABLE PRE-FILLABLE INJECTION SYSTEM 134
  • 10.5 PLAJEX 135
  • 10.6 GX RTF CLEARJECT 135
  • 10.7 GX INNOSAFE 136
  • 10.8 OTHERS 136

11 GLOBAL VACCINE ADMINISTRATION DEVICES MARKET, BY DOSAGE 138

  • 11.1 OVERVIEW 139
  • 11.2 FIXED 142
  • 11.3 VARIABLE 142

12 GLOBAL VACCINE ADMINISTRATION DEVICES MARKET, BY VACCINE TYPE 144

  • 12.1 OVERVIEW 145
  • 12.2 BIVALENT ORAL POLIO VACCINE 148
  • 12.3 BCG VACCINE 148
  • 12.4 TETANUS-DIPHTHERIA VACCINE 149
  • 12.5 DTP-HEPB-HIB VACCINE 150
  • 12.6 INFLUENZA VACCINE 150
  • 12.7 PNEUMOCOCCAL CONJUGATE VACCINE 151
  • 12.8 MEASLES VACCINE 152
  • 12.9 OTHERS 153

13 GLOBAL VACCINE ADMINISTRATION DEVICES MARKET, BY MODALITY 154

  • 13.1 OVERVIEW 155
  • 13.2 AUTOMATIC VACCINE ADMINISTRATION DEVICE 158
  • 13.3 MANUAL VACCINE ADMINISTRATION DEVICE 158

14 GLOBAL VACCINE ADMINISTRATION DEVICES MARKET, BY USABILITY 160

  • 14.1 OVERVIEW 161
  • 14.2 DISPOSABLE 164
  • 14.3 REUSABLE 164

15 GLOBAL VACCINE ADMINISTRATION DEVICES MARKET, BY END USER 166

  • 15.1 OVERVIEW 167
  • 15.2 HOSPITALS 170
  • 15.3 COMMUNITY CENTERS 170
  • 15.4 HOMECARE SETTING 171
  • 15.5 RESEARCH AND ACADEMIC INSTITUTES 172
  • 15.6 AMBULATORY SURGICAL CENTER 172
  • 15.7 OTHERS 173

16 GLOBAL VACCINE ADMINISTRATION DEVICES MARKET, BY DISTRIBUTION CHANNEL 174

  • 16.1 OVERVIEW 175
  • 16.2 DIRECT TENDERS 178
  • 16.3 RETAIL SALES 178
    • 16.3.1 HOSPITAL PHARMACY 179
    • 16.3.2 PHARMACY STORE 179
    • 16.3.3 ONLINE PHARMACY 179
  • 16.4 OTHERS 180

17 GLOBAL VACCINE ADMINISTRATION DEVICES MARKET, BY GEOGRAPHY 181

  • 17.1 OVERVIEW 182
  • 17.2 NORTH AMERICA 188
    • 17.2.1 U.S. 199
    • 17.2.2 CANADA 206
    • 17.2.3 MEXICO 213
  • 17.3 EUROPE 220
    • 17.3.1 GERMANY 231
    • 17.3.2 FRANCE 238
    • 17.3.3 U.K. 245
    • 17.3.4 ITALY 252
    • 17.3.5 NETHERLANDS 259
    • 17.3.6 SPAIN 266
    • 17.3.7 RUSSIA 273
    • 17.3.8 SWITZERLAND 280
    • 17.3.9 TURKEY 287
    • 17.3.10 BELGIUM 294
    • 17.3.11 REST OF EUROPE 301
  • 17.4 ASIA- PACIFIC 302
    • 17.4.1 JAPAN 313
    • 17.4.2 CHINA 320
    • 17.4.3 AUSTRALIA 327
    • 17.4.4 SOUTH KOREA 334
    • 17.4.5 INDIA 341
    • 17.4.6 SINGAPORE 348
    • 17.4.7 MALAYSIA 355
    • 17.4.8 THAILAND 362
    • 17.4.9 INDONESIA 369
    • 17.4.10 PHILIPPINES 376
    • 17.4.11 REST OF ASIA-PACIFIC 383
  • 17.5 SOUTH AMERICA 384
    • 17.5.1 BRAZIL 395
    • 17.5.2 ARGENTINA 402
    • 17.5.3 REST OF SOUTH AMERICA 409
  • 17.6 MIDDLE EAST & AFRICA 416
    • 17.6.1 SAUDI ARABIA 427
    • 17.6.2 SOUTH AFRICA 434
    • 17.6.3 UAE 441
    • 17.6.4 ISRAEL 448
    • 17.6.5 EGYPT 455
    • 17.6.6 REST OF MIDDLE EAST & AFRICA 462

18 GLOBAL VACCINE ADMINISTRATION DEVICES MARKET, COMPANY LANDSCAPE 463

  • 18.1 COMPANY SHARE ANALYSIS: GLOBAL 463
  • 18.2 COMPANY SHARE ANALYSIS: NORTH AMERICA 464
  • 18.3 COMPANY SHARE ANALYSIS: EUROPE 465
  • 18.4 COMPANY SHARE ANALYSIS: ASIA-PACIFIC 466

19 SWOT 467

20 COMPANY PROFILES 468

  • 20.1 BD 468
    • 20.1.1 COMPANY SNAPSHOT 468
    • 20.1.2 REVENUE ANALYSIS 468
    • 20.1.3 COMPANY SHARE ANALYSIS 469
    • 20.1.4 PRODUCT PORTFOLIO 469
    • 20.1.5 RECENT DEVELOPMENT 469
  • 20.2 TERUMO EUROPE NV (A SUBSIDIARY OF TERUMO CORPORATION) 470
    • 20.2.1 COMPANY SNAPSHOT 470
    • 20.2.2 REVENUE ANALYSIS 470
    • 20.2.3 COMPANY SHARE ANALYSIS 471
    • 20.2.4 PRODUCT PORTFOLIO 471
    • 20.2.5 RECENT DEVELOPMENTS 471
  • 20.3 GERRESHEIMER AG 473
    • 20.3.1 COMPANY SNAPSHOT 473
    • 20.3.2 COMPANY SHARE ANALYSIS 473
    • 20.3.3 PRODUCT PORTFOLIO 474
    • 20.3.4 RECENT DEVELOPMENTS 474
  • 20.4 WEST PHARMACEUTICAL SERVICES, INC. 475
    • 20.4.1 COMPANY SNAPSHOT 475
    • 20.4.2 COMPANY SHARE ANALYSIS 475
    • 20.4.3 PRODUCT PORTFOLIO 476
    • 20.4.4 RECENT DEVELOPMENTS 476
  • 20.5 SCHOTT AG (A SUBSIDIARY OF CARL-ZEISS-STIFTUNG) 477
    • 20.5.1 COMPANY SNAPSHOT 477
    • 20.5.2 REVENUE ANALYSIS 477
    • 20.5.3 PRODUCT PORTFOLIO 478
    • 20.5.4 RECENT DEVELOPMENTS 478
  • 20.6 3M 479
    • 20.6.1 COMPANY SNAPSHOT 479
    • 20.6.2 REVENUE ANALYSIS 479
    • 20.6.3 PRODUCT PORTFOLIO 480
    • 20.6.4 RECENT DEVELOPMENT 480
  • 20.7 ANTARES PHARMA 481
    • 20.7.1 COMPANY SNAPSHOT 481
    • 20.7.2 REVENUE ANALYSIS 481
    • 20.7.3 PRODUCT PORTFOLIO 482
    • 20.7.4 RECENT DEVELOPMENTS 482
  • 20.8 BESPAK EUROPE LTD. 483
    • 20.8.1 COMPANY SNAPSHOT 483
    • 20.8.2 PRODUCT PORTFOLIO 483
    • 20.8.3 RECENT DEVELOPMENTS 483
  • 20.9 CORIUM INC. 484
    • 20.9.1 COMPANY SNAPSHOT 484
    • 20.9.2 PRODUCT PORTFOLIO 484
    • 20.9.3 RECENT DEVELOPMENTS 484
  • 20.10 D'ANTONIO CONSULTANTS INTERNATIONAL, INC. 485
    • 20.10.1 COMPANY SNAPSHOT 485
    • 20.10.2 PRODUCT PORTFOLIO 485
    • 20.10.3 RECENT DEVELOPMENT 485
  • 20.11 ENESI 486
    • 20.11.1 COMPANY SNAPSHOT 486
    • 20.11.2 PRODUCT PORTFOLIO 486
    • 20.11.3 RECENT DEVELOPMENTS 486
  • 20.12 IHEALTHNET LLC 488
    • 20.12.1 COMPANY SNAPSHOT 488
    • 20.12.2 PRODUCT PORTFOLIO 488
    • 20.12.3 RECENT DEVELOPMENTS 488
  • 20.13 INJEX UK 489
    • 20.13.1 COMPANY SNAPSHOT 489
    • 20.13.2 PRODUCT PORTFOLIO 489
    • 20.13.3 RECENT DEVELOPMENT 489
  • 20.14 INOVIO PHARMACEUTICALS 490
    • 20.14.1 COMPANY SNAPSHOT 490
    • 20.14.2 REVENUE ANALYSIS 490
    • 20.14.3 PRODUCT PORTFOLIO 491
    • 20.14.4 RECENT DEVELOPMENTS 491
  • 20.15 MEDICAL INTERNATIONAL TECHNOLOGIES (MIT CANADA) INC. 493
    • 20.15.1 COMPANY SNAPSHOT 493
    • 20.15.2 PRODUCT PORTFOLIO 493
    • 20.15.3 RECENT DEVELOPMENT 493
  • 20.16 MICROPOINT TECHNOLGIES 494
    • 20.16.1 COMPANY SNAPSHOT 494
    • 20.16.2 PRODUCT PORTFOLIO 494
    • 20.16.3 RECENT DEVELOPMENT 494
  • 20.17 MYLAN PHARMACEUTICALS INC. (A SUBSIDIARY OF MYLAN N.V.) 495
    • 20.17.1 COMPANY SNAPSHOT 495
    • 20.17.2 REVENUE ANALYSIS 495
    • 20.17.3 PRODUCT PORTFOLIO 495
    • 20.17.4 RECENT DEVELOPMENTS 496
  • 20.18 MYSTIC PHARMACEUTICALS 497
    • 20.18.1 COMPANY SNAPSHOT 497
    • 20.18.2 PRODUCT PORTFOLIO 497
    • 20.18.3 RECENT DEVELOPMENTS 497
  • 20.19 NANOPASS 499
    • 20.19.1 COMPANY SNAPSHOT 499
    • 20.19.2 PRODUCT PORTFOLIO 499
    • 20.19.3 RECENT DEVELOPMENTS 499
  • 20.20 PHARMAJET 501
    • 20.20.1 COMPANY SNAPSHOT 501
    • 20.20.2 PRODUCT PORTFOLIO 501
    • 20.20.3 RECENT DEVELOPMENTS 501
  • 20.21 STAR SYRINGE LIMITED 503
    • 20.21.1 COMPANY SNAPSHOT 503
    • 20.21.2 PRODUCT PORTFOLIO 503
    • 20.21.3 RECENT DEVELOPMENT 503
  • 20.22 VAXXAS PTY LTD 504
    • 20.22.1 COMPANY SNAPSHOT 504
    • 20.22.2 PRODUCT PORTFOLIO 504
    • 20.22.3 RECENT DEVELOPMENT 504

21 QUESTIONNAIRE 505

22 RELATED REPORTS 510

株式会社グローバルインフォメーション
© Copyright 1996-2020, Global Information, Inc. All rights reserved.